Natixis Advisors LP Acquires Stake in Plexus Corp. (NASDAQ:PLXS)

Financial Advisors


Natixis Advisors LP increased its stock position in Plexus Corporation (NASDAQ:PLXS – Get Rating) by 10.2% in the fourth quarter, according to its latest 13F filing with the Securities and Exchange Commission. Institutional investors owned his 22,511 shares of technology company stock after purchasing an additional 2,083 of his shares during the period. Natixis Advisors LP owned approximately 0.08% of his Plexus worth $2,317,000 at the end of the most recent reporting period.

Other big investors have increased or decreased their stakes in the company. Credit Agricole SA bought a new position worth $25,000 in his Plexus in the third quarter. BDO Wealth Advisors LLC purchased new shares in his Plexus worth approximately $27,000 in the third quarter. Ronald Blue Trust Inc. increased his Plexus stock position by 292.8% in the third quarter. Ronald Blue Trust Inc. now owns 436 of his shares worth $34,000 in technology companies after purchasing an additional 325 of his shares during the previous quarter. Wipfli Financial Advisors LLC purchased a new stake in his Plexus worth approximately $74,000 in the third quarter. Finally, UBS Group AG increased his Plexus stock position by 294.9% in the third quarter. UBS Group AG now owns 924 shares worth $81,000 in technology companies after purchasing an additional 690 shares during the previous quarter. 96.01% of the shares are owned by institutional investors and hedge funds.

Analyst upgrades and downgrades

PLXS has been the topic of many recent research papers. JPMorgan Chase & Co. said in his Friday Jan. 27 research report that he lowered his price target on Plexus shares from $90.00 to $86.00, giving the stock an “underweight” rating. StockNews.com began coverage of his Plexus stake in an investigative report on Thursday, March 16. They issued a “Hold” rating on the stock. Needham & Company LLC lowered its price target on Plexus stock from $112.00 to $108.00 and gave the stock a Buy rating in its research report on Friday, January 27. Finally, Sidoti upgraded Plexus’ stock from a ‘neutral’ rating to a ‘buy’ rating and set a price target of $116.00 in his Friday Jan. 27 research report. One equity research analyst gave the stock a sell rating, one gave a hold rating, and four assigned a buy rating. According to MarketBeat data, Plexus currently has a consensus rating of “moderate buy” with an average target price of $107.00.

Plexus trading 0.6% down

NASDAQ:PLXS shares opened Wednesday at $96.31. The company has a market capitalization of $2.67 billion, a PE ratio of 17.35 and a beta of 1.11. The company has a 50-day moving average price of $96.23 and a 200-day moving average price of $100.34. Plexus Corp. hit a 52-week low of $74.53 and a 52-week high of $115.36. The company has a quick ratio of 0.60, a current ratio of 1.44 and a debt to equity ratio of 0.16.

Plexus (NASDAQ:PLXS – Get Rating) last published its quarterly earnings data on Wednesday, January 25th. The tech company posted earnings per share of $1.49 for him in the quarter, beating consensus expectations of $1.47 by $0.02. The company posted $1.09 billion in revenue for the quarter, compared to consensus expectations of $1.11 billion. Plexus had a net profit margin of 3.84% and a return on equity of 14.45%. Plexus quarterly revenue increased 33.8% year over year. During the same period last year, the company recorded his EPS of $0.88. Sell-side analysts expect Plexus Corp. to post earnings of 5.6 per share for the current year.

Plexus company profile

(get rating)

Plexus Corp. is engaged in providing electronic manufacturing services. The company partners with companies to translate concepts into branded products and bring them to market. We partner with customers in the healthcare and life sciences, industrial and commercial, communications, and aerospace and defense market sectors.

References

Quarterly institutional ownership of Plexus (NASDAQ:PLXS)

This instant news alert was generated by Narrative Science Technology and MarketBeat financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Send any questions or comments about this story to contact@marketbeat.com.

Listen to this before considering Plexus.

MarketBeat tracks Wall Street’s most acclaimed and top performing research analysts and the stocks they recommend to clients every day. MarketBeat identified 5 stocks top analysts are quietly whispering to clients to buy now before the broader market catches on…and Plexus wasn’t on the list .

Plexus currently has a “moderate buy” rating among analysts, but the top rated analysts believe these five stocks are better buys.

See 5 stocks here

7 shares to buy and keep forever



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *